Brief: Dermata - Received Shipment Of Spongillaraw Material Which Provides Sufficient Quantities To Manufacture Enough Dmt310 Drug Product For Trial

Dermata Therapeutics

17/05/2022 21:35

May 17 (Reuters) - Dermata Therapeutics Inc  DRMA.O :
    * DERMATA - RECEIVED SHIPMENT OF SPONGILLARAW MATERIAL WHICH
PROVIDES SUFFICIENT QUANTITIES TO MANUFACTURE ENOUGH DMT310 DRUG
PRODUCT FOR TRIAL
    * DERMATA - RECENT SHIPMENT OF RAW MATERIAL WILL BE
SUFFICIENT TO
COMPLETE MANUFACTURING OF REGISTRATION BATCHES TO SUPPORT FILING
OF A NDA


 ((Reuters.Briefs@thomsonreuters.com;))